Literature DB >> 16545011

Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease.

David Albrecht1, Lorena García, Luis Cartier, Ana M Kettlun, Carmen Vergara, Lucia Collados, M Antonieta Valenzuela.   

Abstract

HTLV-1-associated myelopathy/tropical spastic paraparesis (TSP/HAM) is a chronic CNS disease characterized by axomyelinic degeneration of the long axons of corticospinal tracts. Levels of NGF, NT-3, NT-4/5, BDNF, GDNF, CNTF, and FGF-2 were measured in the cerebrospinal fluid (CSF) of 21 TSP/HAM patients and 20 controls. NGF, BDNF, and FGF-2 levels were also determined in 19 patients with HIV motor cognitive motor syndrome, and in 21 subjects diagnosed with Creutzfeldt Jakob disease (CJD). No significant differences were detected in the concentrations of NGF, BDNF, NT-3, NT-4/5, GDNF, and CNTF in the CSF between TSP/HAM patients and controls. FGF-2 was significantly lower in the CSF of the three groups of patients compared with controls; the HIV group exhibited the lowest values. HIV patients differed from TSP/HAM in their significantly higher levels of NGF and lower levels of BDNF and FGF-2, whereas CJD patients differed only in their higher levels of NGF. Immunohistochemical studies were done of trophic factors (NGF and FGF-2) and neurotrophin receptors (trkA and p75) in spinal cord and motor cortical areas from anatomopathological cases of TSP/HAM. Results indicated that NGF is expressed in motoneurons and oligodendrocytes of the posterior column of the spinal cord. FGF-2 was detected in motoneurons and spinal cord vessels. p75 receptor was detected in cortical neurons. The absence of a significant change in the trophic factor levels in TSP/HAM may be attributed to a selective axonal lesion in a slow process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545011     DOI: 10.1089/aid.2006.22.248

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.

Authors:  Rick B Meeker; Winona Poulton; Silva Markovic-Plese; Colin Hall; Kevin Robertson
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

2.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

3.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

Review 4.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

5.  Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.

Authors:  Céline Curis; Florent Percher; Patricia Jeannin; Thomas Montange; Sébastien A Chevalier; Danielle Seilhean; Luis Cartier; Pierre-Olivier Couraud; Olivier Gout; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Philippe V Afonso
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression.

Authors:  Pejman Rahimian; Johnny J He
Journal:  J Neuroinflammation       Date:  2016-09-15       Impact factor: 8.322

7.  HIV-Tat regulates macrophage gene expression in the context of neuroAIDS.

Authors:  Loreto Carvallo; Lillie Lopez; Jorge E Fajardo; Matias Jaureguiberry-Bravo; Andras Fiser; Joan W Berman
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

8.  Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning.

Authors:  Ajay R Bharti; Steven Paul Woods; Ronald J Ellis; Mariana Cherner; Debra Rosario; Michael Potter; Robert K Heaton; Ian P Everall; Eliezer Masliah; Igor Grant; Scott L Letendre
Journal:  HIV AIDS (Auckl)       Date:  2016-04-29

Review 9.  Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.

Authors:  Han Liu; Enquan Xu; Jianuo Liu; Huangui Xiong
Journal:  Brain Sci       Date:  2016-07-22

10.  Comparative DNA Methylation Profiling Reveals an Immunoepigenetic Signature of HIV-related Cognitive Impairment.

Authors:  Michael J Corley; Christian Dye; Michelle L D'Antoni; Mary Margaret Byron; Kaahukane Leite-Ah Yo; Annette Lum-Jones; Beau Nakamoto; Victor Valcour; Ivo SahBandar; Cecilia M Shikuma; Lishomwa C Ndhlovu; Alika K Maunakea
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.